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Canine distemper virus (CDV) is a highly contagious viral pathogen of worldwide 
distribution that can cause lethal disease in domestic dogs and other members of the 
family Canidae. Genetic diversity is found among reference strains and isolates of 
CDV, mainly in the haemagglutinin (H) protein, and this may be associated with the 
increasing incidence of distemper in dogs. CDV was isolated in Vero cells expressing 
canine signalling lymphocyte activation molecule (Vero.DogSLAM) from peripheral 
blood mononuclear cells and spleen of clinically diseased, previously vaccinated South 
African dogs. Direct fluorescence antibody test and electronmicroscopy were used to 
confirm the isolation procedure. Subsequently, RT-PCR was performed on the cell 
culture isolates, the amplified products were purified and the complete H gene was 
sequenced and phylogenetically analysed. The H gene of vaccines in use in South 
Africa was also sequenced and comparative analyses performed. However, the 
sequences obtained from the sick dogs showed 100% nucleotide identity and was 
different to that found in virus strains used in vaccines and in isolates reported from 
other parts of the world in GenBank. The results suggest that a novel CDV lineage 
may be present in South Africa and we conclude that a recent reversion of vaccine 
virus to virulence was not the cause of the clinical signs seen in dogs with a previous 
history of vaccination. 
 




Canine distemper is an acute or subacute, 
highly contagious disease with signs of 
generalized infection, respiratory disease, 
foot pad hyperkeratosis, central nervous 
system disturbance or a combination of 
these (Appel and Summers, 1999). 
Distemper affects wild and domestic 
Canidae as well as many other species of 
carnivores (Appel, 1987). The 
aetiological agent is canine distemper 
virus (CDV) which belongs to the genus 
Morbillivirus within the family 
Paramyxoviridae. CDV contains two 
glycoproteins; haemagglutinin (the 
attachment protein) and a fusion protein, 
which are the major target antigens for 
the host immune system (Murphy et al., 
1999). The introduction of the live 
modified CDV vaccines in the 1950s and 
their extensive use has greatly helped to 
keep the disease under control (Chappuis, 
1995). Notwithstanding, the incidence of 




CDV-related disease in canine population 
throughout the world seems to have 
increased in the last decades and several 
episodes of CDV disease in vaccinated 
animals have been reported (Blixenkron-
Moller et al., 1993; Decaro et al., 2004; 
Gemma et al., 1996; Kai et al., 1993; 
Scagliarini et al., 2003)   
 
Sequence analysis of CDV strains 
identified in different geographical 
settings and from various animal species 
has revealed that the H gene/glycoprotein 
of CDV undergoes a genetic/antigenic 
drift, according to geographic patterns 
related to the location of the circulating 
strains (Bolt et al., 1997; Haas et al., 
1999; Iwatsuki et al., 2000; Martella et 
al., 2006). Herewith, we describe the 
genetic characterization of canine 
distemper viruses detected from naturally 
infected but previously vaccinated dogs 
in South Africa.  
 
 
MATERIALS AND METHODS 
 
Viruses and clinical specimens 
Five CDV strains were sequenced in this 
study.  The CDV-positive cases were 
identified by screening animals affected 
with neurological signs, enteritis, or 
respiratory distress and with a prior 
history of CDV vaccination. These 
samples were submitted by animal 
hospitals and shelters in various parts of 
Pretoria during 2007. Specimens obtained 
from living dogs were limited to blood in 
heparin-containing tubes and spleen from 
dogs that were euthanized or died with 
signs of canine distemper. Peripheral 
blood mononuclear cells (PBMCs) were 
extracted from the blood samples as 
previously described (Woma and van 
Vuuren, 2009), while necropsy tissues 
were processed on receipt as described by 
Seki et al., (2003). Each processed 
specimen was individually inoculated at a 
volume of 0.5 ml into a 25 cm
2 
plastic 
tissue culture flask containing a sub-
confluent monolayer of Vero.DogSLAM 
cells (Woma and van Vuuren, 2009).  
 
Reverse transcription, PCR amplification 
and Sequencing 
Reverse transcription and PCR 
amplification of the H gene of CDV was 
achieved as previously described (Woma 
et al., 2010). Total RNA was obtained 
from 200 µl of supernatants of infected 
cells and 5 commercial CDV vaccines 
(200 µl) , used in South Africa with the 
aid of the RNeasy mini kit (Qiagen®) 
according to the manufacturer’s 
instructions.  The vaccines are not 
produced in South Africa and different 
strains are employed for their production. 
They were initially diluted as prescribed 
by the manufacturers for injection in 
dogs.  
 
The amplified PCR products were 
purified using a QIA quick® PCR 
purification kit (Qiagen®, Southern 
Cross Biotechnology) according to the 
manufacturer’s instructions. Purified 
products were directly sequenced with a 
Big Dye® Terminator v.3.1 cycle 
sequencing kit (AppliedBiosystems) 
according to the manufacturer’s 
instructions. The internal H gene 
sequence primers were P2F, P3R, P5R, 
CDV-HS1, CDV-HforD and CDV-Hr2 
(Table II) (Lan et al., 2006; Pardo et al., 
2005). Precipitation of extension products 
was by the ethanol precipitation protocol 
of AppliedBiosystems®. Sequence trace 
files were electrophoresed using the 
SpectruMedix Genetics analysis system 
SCE 2410 of Inqaba Biotech (South 
Africa) and the ABI 3130XL Genetic 
analyser of the Genetics Laboratory, 
Equine Research Centre, Faculty of 




Sequence data of the full length H gene 
were assembled and edited to a total 
length of 1824 bp using GAP 4 of the 





Staden package (Version 1.6.0 for 
Windows). The open reading frames of 
the assembled sequences were aligned 
with sequences of other H genes collected 
from different parts of the world and 
available in GenBank using MAFFT 
(Katoh et al., 2002; 2005).  The 
nucleotide sequences were translated into 
amino acids using the tranalign 
programme in EMBOSS (Rice et al., 
2000). 
 
 A transversional model with a proportion 
of invariable sites and a gamma-shaped 
distribution of rates across sites 
(TVM+I+Γ) substitution model 
determined by Modeltest v3.7 (Posada 
and Crandall, 1998), PAUP* v4b10 
(Swofford, 2003) and MrBayes v3.1.1 
(Ronquist and Huelsenbeck, 2003; 
Huelsenbeck and Ronquist, 2001) were 
used to explore distance (Neighbour-
joining) and character (Bayesian, 
Maximum likelihood) based phylogenetic 
methods of the nucleotide sequences. The 
consensus trees were edited in MEGA v4 
(Kumar et al., 1994; Tamura et al., 2007). 
The phocine distemper virus (PDV) with 
GenBank accession number AF479277 
was indicated as outgroup in all 3 of the 
analysis types. 
 
Nucleotide Sequence Accession Numbers 
The nucleotide sequence accession 
numbers in the GenBank database of H 
gene sequences of the isolates from dogs 
in South Africa and that of vaccine 
strains available in South Africa are listed 
in Table I. The nucleotide sequence 
accession numbers in the GenBank 
database of H gene sequences of the 
reference strains used in this study are: 
Onderstepoort (AF378705), Convac 




The cytopathic effects of giant 
multinucleated syncytium formation and 
detachment of cells was observed. The 
presence of CDV was confirmed with a 
direct fluorescent antibody test and 
electronmicroscopy as described earlier 
(Woma and van Vuuren, 2009). For the 
purpose of comparison, 5 CDV vaccines 
in use in South Africa were also obtained 
and the RNA extracted. The profiles of 
these field CDV strains and that of the 
vaccines in use in South Africa are 
summarized in table I. The RT-PCRs 
performed according to conditions 
described above resulted in amplicons of 
the expected size of 2100 bp (Figures 2 
and 3) using published primer pairs 
(Table II) (Lan et al., 2006) with minor 
modifications.    The determined 
nucleotide sequences of the amplicons 
were deposited into GenBank under the 
ascension numbers shown in Table I 
(Woma et al., 2010).  
The national center for biotechnology 
information basic alignment search tool 
(NCBI BLAST) was optimized for highly 
similar sequences (megablast) and the 
South African isolates showed 95% 
maximum identity to a Hungarian strain 
(GenBank accession no EF095750), an 
isolates from a Greenlandic dog 
(Z47760), isolate from a Chinese lesser 
panda (AF178039), a German dog isolate 
(X85000), the wild-type strain A75/17 
(AF164967) and a United States ferret 
strain 5804 (AY386315). However, 
sequences from 4 of the commercial 
vaccines (A, B, C, and E) retailed in 
South Africa showed 98 – 99% 
maximum identity to vaccine strain 
(AB212966), the Onderstepoort vaccine 
strain (AF378705), the Lederle vaccine 
strain (DQ903854) and the Convac 
vaccine strain (Z35493). Unexpectedly, 
one of the commercial vaccine (D) 
showed 99% maximum identity to the 
Hungarian strain (EF095750) and the 
Chinese lesser panda isolate (AF178039). 
The sequenced genome fragments from 
each of the field isolates were translated, 
resulting in 607 amino acid (aa) long 
polypeptides, representing the complete 
sequences of the H protein. However, 




only sequences of commercial vaccines D 
and C yielded 607 amino acids. Vaccines 
A, B and E had only 604 amino acids like 
the Onderstepoort and some other earlier 
vaccine strains available in GenBank. In 
the neighbour joining tree (Fig. 1), the 
outgroup (PDV) splits first into the 
lineage America 1 (bootstrap value 
100%), it then splits into the lineage Asia 
2 (bootstrap value 100%) and a group 
consisting of the America 2 (bootstrap 
value 97%), Europe (bootstrap value 
100%) and Asia 1 (95%). The tree then 
finally splits into the Arctic (99%) and 
the South African field isolates groups 
(100%).   
 
We sequenced some of these commercial 
vaccines retailed in South Africa to see if 
there is any genetic variation as compared  
 
to current field isolates. Four (vaccine A, 
B, C, and E) out of the 5 vaccines 
sequenced showed 99% nucleotide 
identity to each other and to the 
Onderstepoort CDV and group together 
with the Onderstepoort strain in lineage 
America 1. The other one (vaccine D) 
showed 99% nucleotide identity to a 
Hungarian vaccine strain (EF095750) and 
to a Chinese CDV isolate from lesser 
panda (AF178039). Vaccine D grouped 
with other CDV strains in lineage 
America 2 which has many CDVs of non 
canine species. These vaccines retailed in 
South Africa are genetically distinct from 
the circulating wild-type strains as has 
been reported in other parts of the world 
(Calderon et al., 2007; Lan et al., 2006). 
 
 
Table I. Profiles of the CDV isolates from this study and the vaccines in use in South 
Africa. 
Isolate/vaccine Breed, sex and age 
(in months) 
Clinical history and findings GenBank 
accession 
numbers 
5L Boerboel, female 
(12) 
Emaciated, cough, oculonasal 
discharge, jaw clamping 
FJ461698 
5SP Cocker Spaniel, 
female (12) 
Emaciated, cough, oculonasal 
discharge, jaw clamping 
FJ461718 
10L Boerboel, male (6) Cough, dyspnoea, jaw clamping FJ461705 
15SP Labrador, male (4) Depressed, vomiting, bloody 
diarrhoea, ocular discharges, 
increased lung sounds 
FJ461706 
25L Yorkie, male (12) Depressed, fever, dehydration, 
anorexia 
FJ461712 
Vaccine A Nobivac® DHPPI  - FJ461701 
Vaccine B Nobivac® PuppyDP  - FJ461709 
Vaccine C GalaxyDA2 PPV - FJ461708 
Vaccine D Vanguard®Plus - FJ461702 
















Table II. Oligonucleotide primers used for RT-PCR amplification and subsequent 
nucleotide sequencing of the H gene 
S/No Primer Orientation Sequence (5’ – 3’) Nucleotide 
Position 
1 CDVff1 Sense TCGAAATCCTATGTGAGATCACT 6897 – 6919 
2 CDVHS2 Antisense ATGCTGGAGATGGTTTAATTCAATCG 8994 – 8969 
3 CDVHS1 Sense AACTTAGGGCTCAGGTAGTCC 7054 – 7074 
4 CDVHforD Sense GACACTGGCTTCCTTGTGTGTAG 7948 – 7970 
5 CDVHr2 Antisense GTTCTTCTTGTTTCTCAGAGG 8198 – 8178 
6 CDVP2F Sense ACTTCCGCGATCTCCACT 7372 – 7389 
7 CDVP3R Antisense ACACTCCGTCTGAGATAGC 7760 - 7742 
8 CDVP5R Antisense GTGAACTGGTCTCCTCTA 8395 – 8378 















Fig.2. RT-PCR amplification of the 2100 bp complete H gene of CDV. M, marker 
(O’Gene Ruler™ 100 bp DNA ladder Plus, Fermentas Life Sciences); lane 1, 2, 9 & 10,  
positive clinical specimens used as positive controls for vaccines RT-PCR; lane 3, ultra 
sterile water used as template RNA; lane 11, Vero.DogSLAM also used as template RNA ( 




































Fig. 3. RT-PCR amplification of the 2100 bp complete H gene of CDV. M, marker 
(O’Gene Ruler™ 100 bp DNA ladder Plus, Fermentas Life Sciences); lane 1 and 2, ultra 
sterile water and Vero.DogSLAM used as negative controls respectively. Lane 3, vaccine 
used as positive control for specimens RT-PCR. Lane 4 – 13, positive clinical specimens. 





The five CDV positive dogs examined in 
this study had history of CDV 
vaccination. An unusual CDV lineage 
was detected in these dogs and 
phylogenetic analysis of the H protein 
sequence of the vaccines in use in South 
Africa showed that the field strains from 
this study are genetically distinct from 
vaccine viruses and other CDV lineages 
circulating in other parts of the world. 
 
Outbreaks of canine distemper have been 
reported among vaccinated dogs (Harder 
et al., 1996; Harder and Osterhaus, 1997; 
Liermann et al., 1998; Momberg-
Jorgensen, 1951; Ott et al., 1957; Simon-
Martinez et al., 2007). Morbillivirus 
vaccination failures have also been 
reported (Blixenkrone-Moller et al., 
1993). Clusters of clinical outbreaks have 
been recorded among human populations 
with documented measles vaccination 
coverage of more than 90% (Gustafson et 
al., 1987). Assuming that quality, 
handling and administration of the 
vaccines were appropriate in the present 
cases of vaccination failure, an 
extraordinarily high infection pressure 
and immune dysfunctions of the 
individuals, which may be inherent or 
due to stress or interference with other 
current infections at the time of 
vaccination or at the time of natural 
exposure, could be important factors 
responsible for lack of protection against 
severe clinical disease. It is possible that 
part of the apparent immunization 
failures in properly vaccinated dogs may 
indicate changes in the biological 
properties of the current field viruses 
(Blixenkrone-Moller et al.,1993). 
 
Vaccination with modified live vaccine 
was performed in the cases obtained in 
this study. Importantly, the CDV strains 
detected in these clinical cases were 
genetically distinct from known vaccine 
strains, as has been demonstrated in 
previous studies of other CDV positive 
cases with history of CDV vaccination 
(Bolt et al., 1997; Calderon et al., 2007; 
Haas et al., 1999; Iwatsuki et al., 2000; 
Lednicky et al., 2004; Maes et al., 2003; 
Martella et al., 2006). These observations 





suggest that a recent reversion of vaccine 
virus to virulence was not likely to be the 
cause of the clinical CDV disease seen in 
dogs for which vaccine had been recently 
used. The possibility was considered that 
vaccine failed to have the intended result 
due to either existing maternal immunity, 
vaccine failures or the emergence of new 
strains that are divergent enough to evade 
immune protection elicited by the 
vaccines used (Pardo et al., 2007). Thus, 
renewed efforts may be required by 
vaccine manufacturers to ensure adequate 
protection following immunization of 
dogs against CDV. More studies on 
genetic characterization will be required 
to evaluate the efficacies of current CDV 
vaccines and develop new vaccines 
against emergence of novel CDV strains. 
A thorough characterization of the 
genetic diversity of CDVs can improve 
our understanding of its emergence, 
epidemiology, and aid development of 
new vaccines and diagnostic tests.  
 
There are other distemper vaccines in the 
global market but the most frequently 
used products in South Africa are 
manufactured by Fort Dodge, Pfizer, 
Intervet, Merial and Virbac. However, it 
is hoped that the effectiveness of the 
currently employed vaccines is not 
partially compromised by the extent of 
genetic variation observed since CDV is a 




For the purpose of this phylogenetic 
analysis, we used the Onderstepoort 
strain (GenBank accession no 
AF378705), the Convac strain (Z35493), 
the Synder Hill strain (AF 259552) and 
the A75/17 strain (AF164967) as 
references. The Onderstepoort CDV was 
derived from the so called Green’s 
distemperoid virus (Green & Carlson, 
1945) which had been isolated from a 
natural distemper case and serially 
passaged in ferrets. The ferret-passaged 
virus was then adapted to chicken eggs 
and passaged in this system numerous 
times, after which it was called 
Onderstepoort-CDV (Haig, 1956). 
Onderstepoort-CDV is considered to be 
completely apathogenic and is used in 
vaccines(Stettler et al., 1997).  The 
Convac strain is also used as a vaccine 
strain but details on its origin is scanty. 
The Synder Hill strain is also used for 
vaccine production. Snyder Hill CDV 
was isolated from a natural case of 
distemper and has been serially passaged 
through direct intracerebral inoculation in 
dogs (Stettler et al., 1997). Several 
features of experimental Synder Hill-
CDV infection are similar to the wild 
type CDV infection (Stettler et al., 1997). 
The A75/17 CDV is regarded as the 
virulent prototype of field CDV isolates. 
A75/17 is a virulent wild strain isolated 
from a dog with spontaneous distemper. 
Under experimental conditions, this virus 
causes a demyelinating disease and 
persistent infection of the CNS as seen in 
natural distemper (Appel, 1969). Current 
South African field isolates examined in 
this study did not cluster with the 
Onderstepoort strain in lineage America 1 
but however, showed about 95% 
nucleotide identity to the A75/17 strain 
on NCBI BLAST. Considering the more 
than 60-year interval between the 
isolation of the Onderstepoort strain and 
our present field isolates, such far genetic 
relationship is not unexpected. 
 
In conclusion, the CDV positive dogs 
with a history of vaccination were 
infected with wild-type CDV having a 
genetic relationship far from the vaccine 
strain, and showed no evidence of 
reversion to virulence of vaccine 
virus.The more commonly reported 
mutations are in the genes coding for the 
hemaglutinin/attachment protein H, the 
fusion protein F and the nucleocapsid 
protein N (Mochizuki et al., 1999). 
Future work should be focused on the 
study of a greater number of clinical 




samples from vaccinated and non-
vaccinated dogs where all the three genes 
(H, F, and N) should be analysed. A 
hemi-nested PCR should be used to 
enable detailed genotyping of current 
African lineage strains to really 
differentiate it from other established 
lineages. Further study is also needed to 
generate information regarding cross-
neutralization (vaccine matching), as well 
as the immunological and biological 
characterization of South African canine 
distemper viruses.  To address the issue 
of whether there is emergence of new 
strains that differ antigenically from 
vaccine strains and thus evading immune 
protection elicited by the vaccines used, 
research in neutralization activities 
amongst vaccine virus and new isolates; 
information of the antibodies of dogs 
after vaccination and research with 
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